Influenza virus glycoprotein-reactive human monoclonal antibodies
- PMID: 32569735
- PMCID: PMC7303604
- DOI: 10.1016/j.micinf.2020.06.003
Influenza virus glycoprotein-reactive human monoclonal antibodies
Abstract
Influenza continues to be a significant public health challenge. Two glycoproteins on the surface of influenza virus, hemagglutinin and neuraminidase, play a prominent role in the process of influenza virus infection and release. Monoclonal antibodies targeting glycoproteins can effectively prevent the spread of the virus. In this review, we summarized currently reported human monoclonal antibodies targeting glycoproteins of influenza A and B viruses.
Keywords: Glycoproteins; Hemagglutinin; Influenza A virus; Influenza B virus; Monoclonal antibodies; Neuraminidase.
Copyright © 2020 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.
Figures
References
-
- WHO. Influenza (Seasonal). https://www.who.int/en/news-room/fact-sheets/detail/influenza-(seasonal)....
-
- Centers for Disease C, Prevention. Pandemic influenza, past pandemics. https://www.cdc.gov/flu/pandemic-resources/basics/past-pandemics.html. 2....
-
- Centers for Disease C, Prevention Isolation of avian influenza A(H5N1) viruses from humans--Hong Kong, May-December 1997. MMWR Morb Mortal Wkly Rep. 1997;46:1204–1207. - PubMed
-
- WHO. Antigenic and genetic characteristics of zoonotic influenza A viruses and development of candidate vaccine viruses for pandemic preparedness. https://www.who.int/influenza/vaccines/virus/characteristics_virus_vacci....
-
- WHO. Influenza at the human-animal interface. https://www.who.int/influenza/human_animal_interface/HAI_Risk_Assessment....
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
